www.dailypolitical.com ·
truist financial corp grows stake in guardant health inc gh
Topic context
This topic has been covered 313545 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedInstitutional investors increased stakes in Guardant Health, a blood-based cancer diagnostics company. The commercial mechanism is an equity investment signal, not a direct product/commodity price or supply chain disruption. Impact is company-specific and weak for broader sectors. No concrete commercial mechanism beyond portfolio allocation.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Truist Financial Corp increased its stake in Guardant Health by 96.9% in Q4, owning 17,940 shares valued at $1,832,000.
- Guardant Health reported Q4 revenue of $281.27 million, a 39.4% increase year-over-year.
- Guardant Health missed earnings estimates with an EPS of ($0.50).
- Stock opened at $98.66, market cap $13.08 billion.
- Other institutional investors (Vanguard, Franklin Resources) also raised holdings.
Related stories
finance.yahoo.com
ncmi q1 2026 earnings transcript 154748256
finance.yahoo.com
transcript valneva q1 2026 earnings 155143868
fool.com
halozyme halo q1 2026 earnings transcript
finance.yahoo.com
aytu aytu q3 2026 earnings 215448614
economictimes.indiatimes.com